Kedrion Biopharma
RYPLAZIM
Manufacturer:
Kedrion Biopharma
Name:
RYPLAZIM
HCPCS Code Descriptor:
Injection, plasminogen, human-tvmh, 1 mg
Category:
J Code
HCPCS:
J2998
NDC(s):
70573-0099-01, 70573-0099-02
Primary Type:
Hematology
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team has identified potential listing errors/discrepancies with the following NDCs:
70573-0099-01
Please contact us regarding potential compendia errors/discrepancies
About:
RYPLAZIM is a Hematology drug manufactured by Kedrion Biopharma and administered via the Intravenous route of administration. The J Code: J2998 is aligned to the drug RYPLAZIM.